An interventional study of DC-CIK immunotherapy in Condylomata Acuminata, sponsored by Shenzhen Second People's Hospital. Status unknown at 1 site in China. Open to participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2017-06-29.
Sponsored by Shenzhen Second People's Hospital · Not applicable, Interventional, and Treatment
Cytokine-induced killer (CIK) cells will be co-cultured with HPV induced dendritic cells (DCs); HPV specific DC-CIK will be induced to Condylomata Acuminata patients using interferon, whose recurrence rate and total cost will be compared to Condylomata Acuminata patients only use interferon.
94 studies on the registry are indexed under Condylomata Acuminata; 7 are open to participants now.
This study's planned enrollment of 80 is below the median of 140 across 77 interventional studies indexed under Condylomata Acuminata.
Browse Condylomata Acuminata studies →Shenzhen Second People's Hospital is the lead sponsor of 48 studies on the registry; 8 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:All patients have typical clinical characters of condyloma, positive for HPV-DNA test; All patients have been treated for cryotherapy or laser plus interferon for over half a year without completely recovery. All patients or their family will sign informed consent and approved by Ethics Committee of Shenzhen Second People's Hospital -
Exclusion Criteria:pregnant, blood disease, contraindication for immune therapy, allergic to interferon
-
dendritic cell-activated cytokine-induced killer cells (DC-CIK) immunotherapy plus interferon intervention
Biological: DC-CIK immunotherapy
saline as placebo plus interferon intervention
Biological: DC-CIK immunotherapy
Cytokine-induced killer (CIK) cells are co-cultured with HPV induced dendritic cells (DCs); HPV specific DC-CIK will be induced to condylomata acuminata patients
Condylomata Acuminata recurrence rate
Condylomata Acuminata recurrence rate in 6 months after treatment
Time frame: 6 months
skin tissue HPV gene
use PCR to testify skin tissue HPV gene
Time frame: 6 months
side effect
evaluate and record side effect of each group
Time frame: 6 months
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shenzhen Second People's Hospital